Strongbridge Biopharma plc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/21 Q2

ended 03/31/21 Q1

ended 12/31/20 FY 2020

ended 09/30/20 Q3

ended 06/30/20 Q2

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Orbimed Advisors LLC

Kovner Bruce, Caxton Corp, Cdk Associates, L.L.C.

Growth Equity Opportunities Fund III, LLC

Wilhoit Scott L.

News Filter

Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc

Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc

Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Announces Dates of Special Shareholder Meetings in Connection With the Proposed Acquisition by Xeris Pharmaceuticals, Inc

Proxies Filter

Proxy related to merger

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Letter from the SEC

Correspondence with the SEC